Obbligazioni TEV
Di seguito è riportato l'elenco delle obbligazioni societarie TEVA PHARMACEUT. SP.ADR. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
| TTEVA.GJTeva Pharmaceutical Finance Co. LLC 0.25% 01-FEB-2026 | 26,91% | 2 K | 85,00% | 0,25% | 2026-02-01 | 22,88 M USD | 1.000,00 USD | 1.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| UUS88167AAF84TEVA PHARMA FIN III 4.10% CALL 01OT46 | 7,44% | 40 K | 72,50% | 4,10% | 2046-10-01 | 2 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA4608603Teva Pharmaceutical Finance Netherlands III BV 6.75% 01-MAR-2028 | 6,96% | 1 M | 99,25% | 6,75% | 2028-03-01 | 255 K USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88163VAD10TEVA PHARM FIN CO LLC 6.15% CALL 01FB36 | 5,75% | 6 K | 102,61% | 6,15% | 2036-02-01 | 789,43 M USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Co. LLC |
| CCH0333827506TEVA 1% 25 | 5,62% | 0 | 99,74% | 1,00% | 2025-07-28 | 350 M CHF | 5.000,00 CHF | 5.000,00 CHF | Teva Pharmaceutical Finance Netherlands IV BV |
| TTEVA5549923Teva Pharmaceutical Finance Netherlands III BV 7.875% 15-SEP-2029 | 5,34% | 500 K | 108,68% | 7,88% | 2029-09-15 | 397,68 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA6082388Teva Pharmaceutical Finance Netherlands III BV 6.0% 01-DEC-2032 | 5,33% | 535 K | 103,57% | 6,00% | 2032-12-01 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA5549924Teva Pharmaceutical Finance Netherlands III BV 8.125% 15-SEP-2031 | 5,23% | 3,8 M | 113,55% | 8,13% | 2031-09-15 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTFABTEVA P.FI.NL III 16/26 | 5,22% | 0 | 97,60% | 3,15% | 2026-10-01 | 1,8 B USD | 1.000,00 USD | 2.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| TTEVA6082389Teva Pharmaceutical Finance Netherlands IV BV 5.75% 01-DEC-2030 | 5,21% | 225 K | 102,30% | 5,75% | 2030-12-01 | 700 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands IV BV |
| TTFAFTEVA P.FI.NL III 18/28 | 5,13% | 0 | 103,78% | 6,75% | 2028-03-01 | 1,25 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88167AAP6TEVA P.F.III 21/27 | 5,04% | 0 | 99,52% | 4,75% | 2027-05-09 | 649,12 M USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| UUS88167AAQ4TEVA P.F.III 21/29 | 4,88% | 0 | 100,79% | 5,13% | 2029-05-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Teva Pharmaceutical Finance Netherlands III BV |
| XXS259280419TEV.P.F.N.II 23/31 | 4,02% | 0 | 119,13% | 7,88% | 2031-09-15 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS308179796TEV.P.F.N.II 25/31 | 3,95% | 0 | 100,86% | 4,13% | 2031-06-01 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660717TEV.P.F.N.II 21/30 | 3,84% | 0 | 102,20% | 4,38% | 2030-05-09 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS259280443TEV.P.F.N.II 23/29 | 3,83% | 0 | 112,81% | 7,38% | 2029-09-15 | 662,58 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS240660709TEV.P.F.N.II 21/27 | 3,35% | 0 | 100,69% | 3,75% | 2027-05-09 | 1,1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS1439749364TEVA PHARMA FIN II 1.625% CALL 15OT28 | 3,01% | 0 | 95,86% | 1,63% | 2028-10-15 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |
| XXS1211044075TEVA PHARMA FIN II 1.875% CALL 31MZ27 | 2,91% | 0 | 98,29% | 1,88% | 2027-03-31 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | Teva Pharmaceutical Finance Netherlands II BV |